AMACR and gastrointestinal stromal tumor: Among the candidates on 5p, we have characterized AMACR at 5p13.3 as a potential amplification-driven oncogene by showing that it has upregulated mRNA with a higher expression level in fresh GIST samples classified as high-risk.